(RTTNews) - SAGE Therapeutics, Inc. (SAGE) released Loss for fourth quarter that decreased from last year and beat the Street estimates. The company's bottom line totaled -$32.71 million, or -$0.55 ...
Wall Street expects a year-over-year decline in earnings on lower revenues when Sage Therapeutics, Inc. (SAGE) reports results for the quarter ended December 2024. While this widely-known consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback